These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29855382)

  • 41. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
    Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations.
    Sakae N; Roemer SF; Bieniek KF; Murray ME; Baker MC; Kasanuki K; Graff-Radford NR; Petrucelli L; Van Blitterswijk M; Rademakers R; Dickson DW
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1782-1796. PubMed ID: 31448566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration.
    May S; Hornburg D; Schludi MH; Arzberger T; Rentzsch K; Schwenk BM; Grässer FA; Mori K; Kremmer E; Banzhaf-Strathmann J; Mann M; Meissner F; Edbauer D
    Acta Neuropathol; 2014 Oct; 128(4):485-503. PubMed ID: 25120191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration.
    Yousef A; Robinson JL; Irwin DJ; Byrne MD; Kwong LK; Lee EB; Xu Y; Xie SX; Rennert L; Suh E; Van Deerlin VM; Grossman M; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2017 Sep; 5(1):68. PubMed ID: 28877758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
    Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
    Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
    Beckers J; Tharkeshwar AK; Van Damme P
    Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
    Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model.
    Swaminathan A; Bouffard M; Liao M; Ryan S; Callister JB; Pickering-Brown SM; Armstrong GAB; Drapeau P
    Hum Mol Genet; 2018 May; 27(10):1754-1762. PubMed ID: 29528390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
    Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
    Pottier C; Zhou X; Perkerson RB; Baker M; Jenkins GD; Serie DJ; Ghidoni R; Benussi L; Binetti G; López de Munain A; Zulaica M; Moreno F; Le Ber I; Pasquier F; Hannequin D; Sánchez-Valle R; Antonell A; Lladó A; Parsons TM; Finch NA; Finger EC; Lippa CF; Huey ED; Neumann M; Heutink P; Synofzik M; Wilke C; Rissman RA; Slawek J; Sitek E; Johannsen P; Nielsen JE; Ren Y; van Blitterswijk M; DeJesus-Hernandez M; Christopher E; Murray ME; Bieniek KF; Evers BM; Ferrari C; Rollinson S; Richardson A; Scarpini E; Fumagalli GG; Padovani A; Hardy J; Momeni P; Ferrari R; Frangipane F; Maletta R; Anfossi M; Gallo M; Petrucelli L; Suh E; Lopez OL; Wong TH; van Rooij JGJ; Seelaar H; Mead S; Caselli RJ; Reiman EM; Noel Sabbagh M; Kjolby M; Nykjaer A; Karydas AM; Boxer AL; Grinberg LT; Grafman J; Spina S; Oblak A; Mesulam MM; Weintraub S; Geula C; Hodges JR; Piguet O; Brooks WS; Irwin DJ; Trojanowski JQ; Lee EB; Josephs KA; Parisi JE; Ertekin-Taner N; Knopman DS; Nacmias B; Piaceri I; Bagnoli S; Sorbi S; Gearing M; Glass J; Beach TG; Black SE; Masellis M; Rogaeva E; Vonsattel JP; Honig LS; Kofler J; Bruni AC; Snowden J; Mann D; Pickering-Brown S; Diehl-Schmid J; Winkelmann J; Galimberti D; Graff C; Öijerstedt L; Troakes C; Al-Sarraj S; Cruchaga C; Cairns NJ; Rohrer JD; Halliday GM; Kwok JB; van Swieten JC; White CL; Ghetti B; Murell JR; Mackenzie IRA; Hsiung GR; Borroni B; Rossi G; Tagliavini F; Wszolek ZK; Petersen RC; Bigio EH; Grossman M; Van Deerlin VM; Seeley WW; Miller BL; Graff-Radford NR; Boeve BF; Dickson DW; Biernacka JM; Rademakers R
    Lancet Neurol; 2018 Jun; 17(6):548-558. PubMed ID: 29724592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.
    Perneel J; Neumann M; Heeman B; Cheung S; Van den Broeck M; Wynants S; Baker M; Vicente CT; Faura J; Rademakers R; Mackenzie IRA
    Acta Neuropathol; 2023 Mar; 145(3):285-302. PubMed ID: 36527486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.
    Riku Y; Duyckaerts C; Boluda S; Plu I; Le Ber I; Millecamps S; Salachas F; ; Yoshida M; Ando T; Katsuno M; Sobue G; Seilhean D
    Acta Neuropathol; 2019 Nov; 138(5):783-793. PubMed ID: 31144027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to
    Longobardi A; Bellini S; Nicsanu R; Pilotto A; Geviti A; Facconi A; Tolassi C; Libri I; Saraceno C; Fostinelli S; Borroni B; Padovani A; Binetti G; Ghidoni R
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers.
    Dickson DW; Baker MC; Jackson JL; DeJesus-Hernandez M; Finch NA; Tian S; Heckman MG; Pottier C; Gendron TF; Murray ME; Ren Y; Reddy JS; Graff-Radford NR; Boeve BF; Petersen RC; Knopman DS; Josephs KA; Petrucelli L; Oskarsson B; Sheppard JW; Asmann YW; Rademakers R; van Blitterswijk M
    Acta Neuropathol Commun; 2019 Oct; 7(1):150. PubMed ID: 31594549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myelin loss in C9orf72 hexanucleotide expansion carriers.
    Sirisi S; Querol-Vilaseca M; Dols-Icardo O; Pegueroles J; Montal V; Muñoz L; Torres S; Ferrer-Raventós P; Iulita MF; Sánchez-Aced É; Blesa R; Illán-Gala I; Molina-Porcel L; Borrego-Ecija S; Sánchez-Valle R; Clarimon J; Belbin O; Fortea J; Lleó A
    J Neurosci Res; 2022 Oct; 100(10):1862-1875. PubMed ID: 35766328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion.
    Udine E; DeJesus-Hernandez M; Tian S; das Neves SP; Crook R; Finch NA; Baker MC; Pottier C; Graff-Radford NR; Boeve BF; Petersen RC; Knopman DS; Josephs KA; Oskarsson B; Da Mesquita S; Petrucelli L; Gendron TF; Dickson DW; Rademakers R; van Blitterswijk M
    Acta Neuropathol; 2024 Apr; 147(1):73. PubMed ID: 38641715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study.
    Benussi L; Rossi G; Glionna M; Tonoli E; Piccoli E; Fostinelli S; Paterlini A; Flocco R; Albani D; Pantieri R; Cereda C; Forloni G; Tagliavini F; Binetti G; Ghidoni R
    J Alzheimers Dis; 2014; 38(4):799-808. PubMed ID: 24064469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The
    Rossi G; Salvi E; Benussi L; Mehmeti E; Geviti A; Bellini S; Longobardi A; Facconi A; Carrara M; Bonvicini C; Nicsanu R; Saraceno C; Ricci M; Giaccone G; Binetti G; Ghidoni R
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients.
    Prudencio M; Gonzales PK; Cook CN; Gendron TF; Daughrity LM; Song Y; Ebbert MTW; van Blitterswijk M; Zhang YJ; Jansen-West K; Baker MC; DeTure M; Rademakers R; Boylan KB; Dickson DW; Petrucelli L; Link CD
    Hum Mol Genet; 2017 Sep; 26(17):3421-3431. PubMed ID: 28637276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.